None.

None known.

If you notice any side effects, please inform your veterinary surgeon.

Meat and offal: Two days.

For animal treatment only.

When adding the veterinary medicinal product to the individual feed ration and when handling this feed, direct contact with eyes, skin and mucous membranes should be avoided. Personal protective equipment should be worn when mixing the veterinary medicinal product or handling the medicated feed: overalls, impervious gloves and either a disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator conforming to European Standard EN 140, with a filter to European Standard EN 143. Wash contaminated skin.

In case of accidental ingestion seek medical advice immediately and show the label to the physician. Because Aivlosin has been shown to cause hypersensitivity reactions in laboratory animals, people with known hypersensitivity to Tylvalosin tartrate should avoid any contact with the product.

The safety of Aivlosin during pregnancy and lactation has not been established in pigs. Use only in accordance with risk/benefit assessment by the responsible veterinarian. Studies in laboratory animals have not produced any evidence of teratogenicity. Maternal toxicity in rodents has been observed at doses of 400 mg tylvalosin per kg bodyweight and above. In mice, a slight reduction in the foetal bodyweight was seen at doses causing maternal toxicity. Cross-resistance to other macrolide antibiotics cannot be excluded.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Veterinary medicinal product subject to prescription.